Structure

Physi-Chem Properties

Molecular Weight:  414.17
Volume:  415.215
LogP:  3.245
LogD:  3.092
LogS:  -4.718
# Rotatable Bonds:  5
TPSA:  72.45
# H-Bond Aceptor:  7
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.695
Synthetic Accessibility Score:  3.416
Fsp3:  0.435
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.709
MDCK Permeability:  3.729417221620679e-05
Pgp-inhibitor:  0.984
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.123

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.134
Plasma Protein Binding (PPB):  79.8868179321289%
Volume Distribution (VD):  0.663
Pgp-substrate:  14.17848014831543%

ADMET: Metabolism

CYP1A2-inhibitor:  0.1
CYP1A2-substrate:  0.972
CYP2C19-inhibitor:  0.573
CYP2C19-substrate:  0.911
CYP2C9-inhibitor:  0.283
CYP2C9-substrate:  0.864
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.918
CYP3A4-inhibitor:  0.798
CYP3A4-substrate:  0.86

ADMET: Excretion

Clearance (CL):  8.522
Half-life (T1/2):  0.362

ADMET: Toxicity

hERG Blockers:  0.21
Human Hepatotoxicity (H-HT):  0.128
Drug-inuced Liver Injury (DILI):  0.872
AMES Toxicity:  0.09
Rat Oral Acute Toxicity:  0.242
Maximum Recommended Daily Dose:  0.541
Skin Sensitization:  0.679
Carcinogencity:  0.036
Eye Corrosion:  0.003
Eye Irritation:  0.024
Respiratory Toxicity:  0.474

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC18211

Natural Product ID:  NPC18211
Common Name*:   Neoisostegane
IUPAC Name:   n.a.
Synonyms:   Neoisostegane
Standard InCHIKey:  UAFHDDGMOVOBAW-DZGCQCFKSA-N
Standard InCHI:  InChI=1S/C23H26O7/c1-25-18-7-12-6-13-11-30-23(24)15(13)8-17-16(14(12)9-19(18)26-2)10-20(27-3)22(29-5)21(17)28-4/h7,9-10,13,15H,6,8,11H2,1-5H3/t13-,15+/m0/s1
SMILES:  COc1cc2C[C@H]3COC(=O)[C@@H]3Cc3c(-c2cc1OC)cc(c(c3OC)OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL483208
PubChem CID:   442918
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001510] Lignan lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22886 Steganotaenia araliacea Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[11720541]
NPO22886 Steganotaenia araliacea Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[6208342]
NPO22886 Steganotaenia araliacea Species Apiaceae Eukaryota stem bark n.a. n.a. PMID[8133298]
NPO22886 Steganotaenia araliacea Species Apiaceae Eukaryota n.a. leaf n.a. Database[Article]
NPO22886 Steganotaenia araliacea Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16145 Apocynum venetum Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO10276 Physochlaina physaloides Species Solanaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16145 Apocynum venetum Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO22886 Steganotaenia araliacea Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16145 Apocynum venetum Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16145 Apocynum venetum Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO10276 Physochlaina physaloides Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens ED50 = 6.6 ug ml-1 PMID[513280]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC18211 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9854 High Similarity NPC143092
0.927 High Similarity NPC72796
0.927 High Similarity NPC44245
0.927 High Similarity NPC211386
0.9241 High Similarity NPC303519
0.9116 High Similarity NPC474514
0.9067 High Similarity NPC325122
0.906 High Similarity NPC477380
0.9054 High Similarity NPC178195
0.9054 High Similarity NPC348849
0.9028 High Similarity NPC321958
0.9028 High Similarity NPC321696
0.9 High Similarity NPC865
0.9 High Similarity NPC477885
0.8958 High Similarity NPC318286
0.8958 High Similarity NPC327651
0.8951 High Similarity NPC218510
0.8951 High Similarity NPC76415
0.8929 High Similarity NPC471182
0.8926 High Similarity NPC273578
0.8919 High Similarity NPC220577
0.8912 High Similarity NPC149505
0.8889 High Similarity NPC474036
0.8889 High Similarity NPC61141
0.8889 High Similarity NPC326144
0.8881 High Similarity NPC40237
0.8881 High Similarity NPC210354
0.8881 High Similarity NPC176586
0.8881 High Similarity NPC151423
0.8836 High Similarity NPC104024
0.8836 High Similarity NPC101755
0.8836 High Similarity NPC65574
0.8836 High Similarity NPC80230
0.8836 High Similarity NPC304687
0.8819 High Similarity NPC470811
0.8819 High Similarity NPC106920
0.8819 High Similarity NPC477697
0.8819 High Similarity NPC477696
0.8819 High Similarity NPC273657
0.8784 High Similarity NPC316989
0.8776 High Similarity NPC198129
0.8776 High Similarity NPC252281
0.8776 High Similarity NPC477375
0.8776 High Similarity NPC327352
0.8767 High Similarity NPC87295
0.8759 High Similarity NPC177644
0.8759 High Similarity NPC218841
0.8759 High Similarity NPC475000
0.8759 High Similarity NPC92693
0.8759 High Similarity NPC191158
0.8742 High Similarity NPC238834
0.8725 High Similarity NPC210642
0.8725 High Similarity NPC13985
0.8716 High Similarity NPC477376
0.8716 High Similarity NPC477374
0.8716 High Similarity NPC262455
0.8716 High Similarity NPC322426
0.8716 High Similarity NPC85141
0.8716 High Similarity NPC177476
0.8705 High Similarity NPC141493
0.8705 High Similarity NPC184928
0.8699 High Similarity NPC27106
0.8686 High Similarity NPC223807
0.8667 High Similarity NPC104353
0.8667 High Similarity NPC473732
0.8662 High Similarity NPC209229
0.8654 High Similarity NPC477884
0.8652 High Similarity NPC185680
0.8652 High Similarity NPC256776
0.8652 High Similarity NPC145722
0.8649 High Similarity NPC40654
0.8649 High Similarity NPC262804
0.8649 High Similarity NPC325720
0.8649 High Similarity NPC304821
0.8649 High Similarity NPC316676
0.8649 High Similarity NPC477879
0.8643 High Similarity NPC475856
0.8639 High Similarity NPC193779
0.863 High Similarity NPC87883
0.8623 High Similarity NPC149008
0.8623 High Similarity NPC283114
0.8623 High Similarity NPC207702
0.8609 High Similarity NPC178574
0.8609 High Similarity NPC65591
0.8609 High Similarity NPC475116
0.8609 High Similarity NPC474606
0.86 High Similarity NPC475756
0.86 High Similarity NPC474975
0.8581 High Similarity NPC295297
0.8581 High Similarity NPC319749
0.8581 High Similarity NPC191352
0.8581 High Similarity NPC258322
0.8571 High Similarity NPC470932
0.8562 High Similarity NPC474288
0.8562 High Similarity NPC301897
0.8562 High Similarity NPC29727
0.8561 High Similarity NPC153547
0.8553 High Similarity NPC473425
0.8544 High Similarity NPC471180
0.8543 High Similarity NPC471154
0.8543 High Similarity NPC272566
0.8542 High Similarity NPC470962
0.8533 High Similarity NPC473989
0.8531 High Similarity NPC32189
0.8526 High Similarity NPC280778
0.8516 High Similarity NPC474770
0.8514 High Similarity NPC213482
0.8514 High Similarity NPC474054
0.8506 High Similarity NPC19947
0.8506 High Similarity NPC207584
0.8506 High Similarity NPC181168
0.8506 High Similarity NPC163527
0.8506 High Similarity NPC115281
0.85 High Similarity NPC178737
0.8487 Intermediate Similarity NPC126405
0.8487 Intermediate Similarity NPC217708
0.8487 Intermediate Similarity NPC77237
0.8487 Intermediate Similarity NPC308739
0.8487 Intermediate Similarity NPC245948
0.8487 Intermediate Similarity NPC53669
0.8487 Intermediate Similarity NPC16791
0.8487 Intermediate Similarity NPC477377
0.8487 Intermediate Similarity NPC24562
0.8487 Intermediate Similarity NPC297271
0.8477 Intermediate Similarity NPC224472
0.8471 Intermediate Similarity NPC475865
0.8467 Intermediate Similarity NPC474965
0.8467 Intermediate Similarity NPC174512
0.8467 Intermediate Similarity NPC474347
0.8467 Intermediate Similarity NPC125570
0.8467 Intermediate Similarity NPC474393
0.8467 Intermediate Similarity NPC477698
0.8467 Intermediate Similarity NPC216223
0.8467 Intermediate Similarity NPC477695
0.8467 Intermediate Similarity NPC293757
0.8467 Intermediate Similarity NPC145569
0.8467 Intermediate Similarity NPC668
0.8456 Intermediate Similarity NPC183083
0.8456 Intermediate Similarity NPC137352
0.8452 Intermediate Similarity NPC125713
0.8452 Intermediate Similarity NPC474043
0.8442 Intermediate Similarity NPC32373
0.8442 Intermediate Similarity NPC237946
0.8442 Intermediate Similarity NPC150227
0.8438 Intermediate Similarity NPC477883
0.8431 Intermediate Similarity NPC198461
0.8431 Intermediate Similarity NPC30009
0.8431 Intermediate Similarity NPC312763
0.8431 Intermediate Similarity NPC103197
0.8421 Intermediate Similarity NPC475229
0.8421 Intermediate Similarity NPC477378
0.8414 Intermediate Similarity NPC201404
0.8414 Intermediate Similarity NPC290714
0.8414 Intermediate Similarity NPC53722
0.8411 Intermediate Similarity NPC477381
0.8411 Intermediate Similarity NPC470916
0.8403 Intermediate Similarity NPC11453
0.8403 Intermediate Similarity NPC143895
0.8397 Intermediate Similarity NPC470637
0.8397 Intermediate Similarity NPC96593
0.8397 Intermediate Similarity NPC63061
0.8389 Intermediate Similarity NPC474446
0.8387 Intermediate Similarity NPC190020
0.8387 Intermediate Similarity NPC77679
0.8387 Intermediate Similarity NPC84935
0.8385 Intermediate Similarity NPC471181
0.838 Intermediate Similarity NPC102256
0.8377 Intermediate Similarity NPC79998
0.8377 Intermediate Similarity NPC234730
0.8377 Intermediate Similarity NPC476065
0.8377 Intermediate Similarity NPC199926
0.8369 Intermediate Similarity NPC470624
0.8369 Intermediate Similarity NPC476399
0.8369 Intermediate Similarity NPC237169
0.8367 Intermediate Similarity NPC229172
0.8367 Intermediate Similarity NPC230538
0.8367 Intermediate Similarity NPC253481
0.8367 Intermediate Similarity NPC253722
0.8367 Intermediate Similarity NPC103637
0.8367 Intermediate Similarity NPC31751
0.8367 Intermediate Similarity NPC36531
0.8367 Intermediate Similarity NPC46180
0.8365 Intermediate Similarity NPC83049
0.8365 Intermediate Similarity NPC118162
0.8365 Intermediate Similarity NPC320471
0.8356 Intermediate Similarity NPC103448
0.8356 Intermediate Similarity NPC216434
0.8355 Intermediate Similarity NPC164082
0.8355 Intermediate Similarity NPC477379
0.8355 Intermediate Similarity NPC477700
0.8354 Intermediate Similarity NPC469475
0.8354 Intermediate Similarity NPC469518
0.8345 Intermediate Similarity NPC285725
0.8345 Intermediate Similarity NPC50683
0.8345 Intermediate Similarity NPC88297
0.8345 Intermediate Similarity NPC186845
0.8345 Intermediate Similarity NPC9891
0.8345 Intermediate Similarity NPC112571
0.8344 Intermediate Similarity NPC288149
0.8344 Intermediate Similarity NPC239890

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC18211 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8487 Intermediate Similarity NPD37 Approved
0.8462 Intermediate Similarity NPD7199 Phase 2
0.8442 Intermediate Similarity NPD4967 Phase 2
0.8442 Intermediate Similarity NPD4966 Approved
0.8442 Intermediate Similarity NPD4965 Approved
0.8354 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6234 Discontinued
0.8158 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8112 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD6232 Discontinued
0.805 Intermediate Similarity NPD5494 Approved
0.8025 Intermediate Similarity NPD7473 Discontinued
0.7975 Intermediate Similarity NPD7228 Approved
0.795 Intermediate Similarity NPD7229 Phase 3
0.7927 Intermediate Similarity NPD5844 Phase 1
0.7911 Intermediate Similarity NPD3817 Phase 2
0.7875 Intermediate Similarity NPD919 Approved
0.7867 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD3882 Suspended
0.7848 Intermediate Similarity NPD1465 Phase 2
0.7843 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD2533 Approved
0.7792 Intermediate Similarity NPD2534 Approved
0.7792 Intermediate Similarity NPD2532 Approved
0.7791 Intermediate Similarity NPD3926 Phase 2
0.7784 Intermediate Similarity NPD7240 Approved
0.7736 Intermediate Similarity NPD7819 Suspended
0.7733 Intermediate Similarity NPD2438 Suspended
0.773 Intermediate Similarity NPD3705 Approved
0.7714 Intermediate Similarity NPD17 Approved
0.7683 Intermediate Similarity NPD5242 Approved
0.7673 Intermediate Similarity NPD1934 Approved
0.7667 Intermediate Similarity NPD3748 Approved
0.7635 Intermediate Similarity NPD2979 Phase 3
0.7628 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD2801 Approved
0.7613 Intermediate Similarity NPD6799 Approved
0.7606 Intermediate Similarity NPD1281 Approved
0.7591 Intermediate Similarity NPD5283 Phase 1
0.7584 Intermediate Similarity NPD6355 Discontinued
0.7578 Intermediate Similarity NPD5353 Approved
0.7564 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD1247 Approved
0.7552 Intermediate Similarity NPD1608 Approved
0.7551 Intermediate Similarity NPD3027 Phase 3
0.7547 Intermediate Similarity NPD6599 Discontinued
0.7545 Intermediate Similarity NPD3818 Discontinued
0.7544 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD3018 Phase 2
0.7532 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD4110 Phase 3
0.7516 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2796 Approved
0.75 Intermediate Similarity NPD6100 Approved
0.75 Intermediate Similarity NPD6099 Approved
0.7468 Intermediate Similarity NPD1243 Approved
0.7468 Intermediate Similarity NPD920 Approved
0.7467 Intermediate Similarity NPD230 Phase 1
0.7448 Intermediate Similarity NPD1283 Approved
0.7431 Intermediate Similarity NPD2981 Phase 2
0.7419 Intermediate Similarity NPD3750 Approved
0.7407 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD4060 Phase 1
0.7399 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1651 Approved
0.7391 Intermediate Similarity NPD6386 Approved
0.7391 Intermediate Similarity NPD6385 Approved
0.7386 Intermediate Similarity NPD2531 Phase 2
0.7379 Intermediate Similarity NPD2982 Phase 2
0.7379 Intermediate Similarity NPD2983 Phase 2
0.7378 Intermediate Similarity NPD3749 Approved
0.7342 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6166 Phase 2
0.7321 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD4628 Phase 3
0.7308 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD3787 Discontinued
0.7297 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD1613 Approved
0.7285 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD3267 Approved
0.7279 Intermediate Similarity NPD3266 Approved
0.7278 Intermediate Similarity NPD1511 Approved
0.7273 Intermediate Similarity NPD7075 Discontinued
0.7273 Intermediate Similarity NPD5691 Approved
0.7267 Intermediate Similarity NPD6798 Discontinued
0.7254 Intermediate Similarity NPD5536 Phase 2
0.7251 Intermediate Similarity NPD7074 Phase 3
0.7248 Intermediate Similarity NPD4908 Phase 1
0.7248 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD6801 Discontinued
0.7233 Intermediate Similarity NPD3688 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD3146 Approved
0.7225 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD8032 Phase 2
0.7208 Intermediate Similarity NPD1510 Phase 2
0.7208 Intermediate Similarity NPD7033 Discontinued
0.7202 Intermediate Similarity NPD5710 Approved
0.7202 Intermediate Similarity NPD5711 Approved
0.7193 Intermediate Similarity NPD7054 Approved
0.7188 Intermediate Similarity NPD1512 Approved
0.7178 Intermediate Similarity NPD7411 Suspended
0.7178 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD1240 Approved
0.7162 Intermediate Similarity NPD2797 Approved
0.7153 Intermediate Similarity NPD5585 Approved
0.7152 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3268 Approved
0.7152 Intermediate Similarity NPD6190 Approved
0.7152 Intermediate Similarity NPD1296 Phase 2
0.7152 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7472 Approved
0.7143 Intermediate Similarity NPD8127 Discontinued
0.7143 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6959 Discontinued
0.7134 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD1933 Approved
0.7123 Intermediate Similarity NPD1610 Phase 2
0.7117 Intermediate Similarity NPD4380 Phase 2
0.7115 Intermediate Similarity NPD5763 Approved
0.7115 Intermediate Similarity NPD5762 Approved
0.7115 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7768 Phase 2
0.7086 Intermediate Similarity NPD4625 Phase 3
0.7078 Intermediate Similarity NPD1607 Approved
0.707 Intermediate Similarity NPD2897 Discontinued
0.707 Intermediate Similarity NPD1549 Phase 2
0.7063 Intermediate Similarity NPD4357 Discontinued
0.7051 Intermediate Similarity NPD2935 Discontinued
0.7051 Intermediate Similarity NPD4476 Approved
0.7051 Intermediate Similarity NPD3539 Phase 1
0.7051 Intermediate Similarity NPD4477 Approved
0.7048 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD5402 Approved
0.7039 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD3764 Approved
0.7035 Intermediate Similarity NPD3751 Discontinued
0.7029 Intermediate Similarity NPD7808 Phase 3
0.7027 Intermediate Similarity NPD5005 Approved
0.7027 Intermediate Similarity NPD5006 Approved
0.702 Intermediate Similarity NPD6832 Phase 2
0.7018 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD447 Suspended
0.7012 Intermediate Similarity NPD6875 Approved
0.7012 Intermediate Similarity NPD6876 Approved
0.7011 Intermediate Similarity NPD6797 Phase 2
0.7007 Intermediate Similarity NPD1611 Approved
0.7006 Intermediate Similarity NPD3540 Phase 1
0.7006 Intermediate Similarity NPD6002 Phase 3
0.7006 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6004 Phase 3
0.7006 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD6005 Phase 3
0.7 Intermediate Similarity NPD7124 Phase 2
0.7 Intermediate Similarity NPD6652 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.6993 Remote Similarity NPD6233 Phase 2
0.6989 Remote Similarity NPD7680 Approved
0.6987 Remote Similarity NPD2799 Discontinued
0.6986 Remote Similarity NPD4626 Approved
0.6986 Remote Similarity NPD1778 Approved
0.6983 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6982 Remote Similarity NPD6746 Phase 2
0.698 Remote Similarity NPD1876 Approved
0.6975 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6974 Remote Similarity NPD7095 Approved
0.6971 Remote Similarity NPD7685 Pre-registration
0.6971 Remote Similarity NPD6559 Discontinued
0.6971 Remote Similarity NPD7251 Discontinued
0.6966 Remote Similarity NPD8434 Phase 2
0.6964 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6951 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6951 Remote Similarity NPD4005 Discontinued
0.6951 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6948 Remote Similarity NPD943 Approved
0.6946 Remote Similarity NPD5978 Approved
0.6946 Remote Similarity NPD5977 Approved
0.6943 Remote Similarity NPD1551 Phase 2
0.6933 Remote Similarity NPD5403 Approved
0.6933 Remote Similarity NPD6662 Clinical (unspecified phase)
0.6928 Remote Similarity NPD5110 Phase 2
0.6928 Remote Similarity NPD5111 Phase 2
0.6928 Remote Similarity NPD5109 Approved
0.6923 Remote Similarity NPD6111 Discontinued
0.6919 Remote Similarity NPD4481 Phase 3
0.6919 Remote Similarity NPD2403 Approved
0.6918 Remote Similarity NPD2654 Approved
0.6918 Remote Similarity NPD6674 Discontinued
0.6918 Remote Similarity NPD2800 Approved
0.6914 Remote Similarity NPD5401 Approved
0.6913 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6913 Remote Similarity NPD4359 Approved
0.6913 Remote Similarity NPD4749 Approved
0.6909 Remote Similarity NPD7028 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data